Hey Doog, long time no see, lol. Just checking in as we both had been in this company for 5-6yrs. I had made the decision to unload completely upon the Glucophage acceptance run-up on 2-24-17, in the 2.55-2.85 range. Coincidentally that was 1 yr. to the day that the Keppra acceptance was announced with no movement on commercialization of that product. I wasn't optimistic about Glucophage fairing any better with the companies history. At my peak I had well over 300k shares so the run-up helped me unload as we were around the $2 range previously.
I had bowed out gracefully still hoping this company could turn the corner for the sake of the good people still invested here. I will say for the record I did not envision the Adcom results but it most certainly reflects a pattern.
I guess for me, being invested in a company for so long, I let my vision cloud my better judgement. That being said my best to those still invested here. I think new money can make a profit at these levels in due time.
News 
Market Data 
Discover 
AI
